Molbio Diagnostics Limited has announced the outcome of its Board Meeting held on November 05, 2026. The board approved the unaudited financial results (standalone and consolidated) for the quarter and half-year ended September 30, 2026. A limited review report, along with the financial results, has been provided. The meeting also covered the approval of a monitoring agency report on IPO proceeds utilization and noted the resignation of Dr. Kuldeep Singh Sachdeva.
Molbio Diagnostics Board Meeting Outcome
Molbio Diagnostics Limited convened its Board Meeting on Thursday, November 05, 2026, to transact key business matters. A primary agenda item was the approval of the unaudited financial results, both standalone and consolidated, for the quarter and half-year ended September 30, 2026. These results, along with the accompanying Limited Review Report, have been submitted and marked as “Annexure-A”.
Key Decisions and Updates
The company’s statutory auditors have issued an unmodified opinion on the Limited Review Report for the financial results of the specified period, as per Regulation 33(3)(d) of the SEBI Listing Regulations. Additionally, the Board approved the Monitoring Agency Report concerning the utilization of proceeds from the company’s Initial Public Offer (IPO) for the quarter ended September 30, 2026. This report was previously approved by the Audit Committee.
Personnel Changes and Appointments
The Board also noted the resignation of Dr. Kuldeep Singh Sachdeva, who held the positions of President & Chief Medical Officer, and Senior Management Personnel (SMP) of the company. Further details regarding this disclosure are provided in “Annexure-B”. In a significant appointment, M/s. Rakesh Hulihalli & Associates, a Practising Company Secretaries firm, has been appointed as the Secretarial Auditor for a term of five consecutive years, commencing from FY 2026-27 to FY 2030-31. This appointment is subject to shareholder approval, with further information available in “Annexure-C”.
Postal Ballot and Communication
The Board further approved the notice for a Postal Ballot through a remote e-voting process. A Director or Key Managerial Personnel (KMP) has been authorized to determine the cut-off date and dispatch the postal ballot notice to eligible members. The Board Meeting commenced at 03:36 P.M. and concluded at 04:03 P.M. This information is also accessible on the company’s website in compliance with Regulation 46 of the SEBI Listing Regulations.
Source: BSE
